Sanner Rebranded Gilero Unit and Expanded Chicago Facility
The medical device firm unified its branding while increasing its development footprint in the Midwest.
Updated on Sept. 24, 2026 in Healthcare
Live Poll
Does the consolidation of medical device manufacturers into larger entities ultimately benefit the healthcare industry?
Sanner has completed a rebranding of its subsidiary Gilero to the Sanner name. The company also expanded its Chicago innovation facility to bolster medical device development.
Why it matters
The move integrates the firm into the Midwest medtech ecosystem by merging pharmaceutical packaging with medical device development. This consolidation provides a singular platform for clients to handle design and production.
Sanner maintains a global workforce of more than 850 employees. The firm supplies products to 150 countries worldwide.
The players
Sanner
This global medical device and pharmaceutical packaging company maintains manufacturing sites in Germany, France, Hungary, China, and the US.
GHO Capital
This is a private equity firm that became the majority owner of Sanner in November 2021.
mHUB
This is a Chicago-based innovation center that provides startups and companies access to advanced manufacturing and prototyping equipment.
The details
The expanded Chicago facility now features a human factors laboratory and provides direct access to the mHUB Innovation Center. This enables specialized capabilities such as rapid prototyping, laser cutting, and selective laser sintering 3D printing.
Timeline
Sanner was founded in 1894.
GHO Capital acquired a majority stake in Sanner in November 2021.
Sanner acquired Gilero in 2024.
Market Landscape
The expansion follows the trajectory established by the 2024 acquisition of Gilero by Sanner. By consolidating its brands and physical footprint, the firm strengthens its competitive position against other medical device development platforms in North America.
Clients and partners in the medical device sector will now access a unified suite of development services under a single corporate entity. The integration aims to streamline the transition from initial human-centered design to final production.
The takeaway
Companies in the medical device industry are increasingly consolidating R&D and manufacturing to shorten product development cycles. This shift emphasizes the value of regional innovation hubs in supporting technical testing and rapid prototyping.
Further reading
For more on industry developments, see Healthcare.
Source note: This article includes information reported by PlasticsToday.
Live Poll
Does the consolidation of medical device manufacturers into larger entities ultimately benefit the healthcare industry?
